Skin Neoplasms Clinical Trial
Official title:
Reducing Skin Cancer Risk in Childhood Cancer Survivors
The objective of this study is to determine the impact of a 12-month patient activation and
education intervention on skin cancer early detection practices among childhood cancer
survivors treated with radiation. This randomized controlled trial uses a three-group design.
Our specific aims are to: (1) Determine the impact of a Patient Activation and Education
intervention with and without physician activation and teledermatology on skin cancer early
detection practices, (2) Determine the impact of the intervention on time to diagnosis, and
(3) Estimate the cost and cost-effectiveness of the intervention as a secondary outcome.
There are currently more than 420,000 Americans who are long-term survivors of childhood and
adolescent cancer. While these groups have greatly benefited from recent medical advances,
primarily increasing overall survival rates, treatment advances have come at a cost. It is
now clear that childhood radiation therapy has caused survivors to be at extremely high risk
for non-melanoma skin cancer (NMSC) and increased risk of melanoma. Early detection is
crucial to reduce the morbidity caused by NMSCs and the morbidity and mortality incurred due
to melanoma. Both patient and provider action are needed to detect and treat early skin
cancers and to find new solutions to ensure expedited follow-up care and treatment,
especially among those who live where they have little access to dermatologists.
The objective of this study is to determine the impact of a 12-month patient activation and
education intervention on skin cancer early detection practices among childhood cancer
survivors treated with radiation. All participants will receive text messages encouraging
them to examine their skin and request physician examinations while concurrently driving them
to a study website that provides education related to the associated skills, and reinforces
and expands the text messages. To reduce skin cancers among this young and dispersed patient
population, this study will address several key issues: (1) how to provide patients with the
skills needed to conduct effective skin self-examinations; 2) how to prompt action from
patient's physicians when worrisome moles and lesions are found; and 3) how to ensure rapid
access to dermatologic exams, which in some parts of the US can take weeks or months to
schedule.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00027586 -
Imatinib Mesylate in Treating Patients With Metastatic Melanoma
|
Phase 2 | |
Not yet recruiting |
NCT02230462 -
Patient Satisfaction After Facial Reconstruction
|
N/A | |
Terminated |
NCT02900248 -
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
|
||
Completed |
NCT00224744 -
Prospective and Randomized Study to Evaluate Interest of Ultracision Use in Inguinal Lymph Nodes Curage
|
Phase 3 | |
Completed |
NCT03132012 -
Skin Health in Young Adults - Preventing Indoor Tanning and Promoting Sun Protection
|
N/A | |
Terminated |
NCT00865878 -
ALA-PDT Versus Vehicle PDT for Treatment of AK and Reduction of New NMSC in Solid Organ Transplant Recipients
|
Phase 2 | |
Not yet recruiting |
NCT05359419 -
Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities
|
Phase 4 | |
Active, not recruiting |
NCT00001813 -
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
|
||
Completed |
NCT02147080 -
A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults
|
N/A | |
Completed |
NCT00007631 -
Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer
|
Phase 3 | |
Completed |
NCT00847912 -
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial
|
Phase 4 | |
Recruiting |
NCT02836548 -
HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
|
Phase 1/Phase 2 | |
Completed |
NCT01482104 -
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
|
N/A | |
Enrolling by invitation |
NCT04630886 -
Use of Tranexamic Acid in Reduction of Post-Op Complications in Mohs Micrographic Surgery
|
Early Phase 1 | |
Completed |
NCT03012581 -
Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
|
Phase 2 | |
Withdrawn |
NCT02813902 -
A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
|
Phase 1 | |
Not yet recruiting |
NCT02408835 -
Negative Pressure Wound Therapy in Groin Dissection
|
N/A | |
Completed |
NCT00204789 -
Difluoromethylornithine (DFMO) Chemoprevention of Skin Cancer in Organ Transplant Recipients
|
Phase 2 | |
Completed |
NCT02310503 -
Spanish Registry of Mohs Surgery
|
||
Active, not recruiting |
NCT04267861 -
M7824 Related Adverse Effects in Adults With Cancer
|